Literature DB >> 11487019

Interendothelial junctions and their role in the control of angiogenesis, vascular permeability and leukocyte transmigration.

E Dejana1, R Spagnuolo, G Bazzoni.   

Abstract

Endothelial cell-cell junctions play an important role in vascular hemostasis. The two junctional proteins VE-cadherin and JAM-1 are localized at adherens and tight junctions, respectively. VE-cadherin is only expressed by endothelial cells, suggesting that it can exert cell specific function. Absence of VE-cadherin or blocking of its adhesive activity prevents a normal organization of new vascular structures, suggesting that VE-cadherin may be a molecular target of antiangiogenic therapy. In addition, the ability of permeability-increasing agents and adherent leukocytes to modify VE-cadherin/catenin organization may be related to a role in the control of vascular permeability and leukocyte infiltration. JAM-1 is an integral membrane protein expressed in endothelial and epithelial cells. Its extracellular domain can dimerize and bind homophilically. The intracellular domain (and in particular a PDZ-binding motif) enables JAM-1 to interact with structural and signaling proteins. Study of the molecular interactions of JAM-1 may help explain mechanisms of JAM-mediated function, such as control of paracellular permeability and leukocyte transmigration.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11487019

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  58 in total

Review 1.  Cell physiology as a variable in gene transfer to endothelium.

Authors:  Philip L Leopold
Journal:  Curr Atheroscler Rep       Date:  2003-05       Impact factor: 5.113

2.  Role of exosomes released by chronic myelogenous leukemia cells in angiogenesis.

Authors:  Simona Taverna; Anna Flugy; Laura Saieva; Elise C Kohn; Alessandra Santoro; Serena Meraviglia; Giacomo De Leo; Riccardo Alessandro
Journal:  Int J Cancer       Date:  2011-08-08       Impact factor: 7.396

3.  Transference of recombinant VE-cadherin cytoplasmic domain alters endothelial junctional integrity and porcine microvascular permeability.

Authors:  Mingzhang Guo; Mack H Wu; Harris J Granger; Sarah Y Yuan
Journal:  J Physiol       Date:  2004-01-01       Impact factor: 5.182

4.  Metabolic regulation of intestinal epithelial barrier during inflammation.

Authors:  Sean P Colgan; Valerie F Curtis; Jordi M Lanis; Louise E Glover
Journal:  Tissue Barriers       Date:  2015-04-03

5.  Effects of Ebola virus glycoproteins on endothelial cell activation and barrier function.

Authors:  Victoria M Wahl-Jensen; Tatiana A Afanasieva; Jochen Seebach; Ute Ströher; Heinz Feldmann; Hans-Joachim Schnittler
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

Review 6.  Mechanisms of the blood-brain barrier disruption in HIV-1 infection.

Authors:  Michal Toborek; Yong Woo Lee; Govinder Flora; Hong Pu; Ibolya E András; Edward Wylegala; Bernhard Hennig; Avindra Nath
Journal:  Cell Mol Neurobiol       Date:  2005-02       Impact factor: 5.046

Review 7.  Regulation of microvascular permeability by vascular endothelial growth factors.

Authors:  D O Bates; N J Hillman; B Williams; C R Neal; T M Pocock
Journal:  J Anat       Date:  2002-06       Impact factor: 2.610

8.  Remodeling of endothelial adherens junctions by Kaposi's sarcoma-associated herpesvirus.

Authors:  Mandana Mansouri; Patrick P Rose; Ashlee V Moses; Klaus Früh
Journal:  J Virol       Date:  2008-07-30       Impact factor: 5.103

9.  Kaposi's sarcoma-associated herpesvirus disrupts adherens junctions and increases endothelial permeability by inducing degradation of VE-cadherin.

Authors:  Li-Wu Qian; Whitney Greene; Fengchun Ye; Shou-Jiang Gao
Journal:  J Virol       Date:  2008-09-24       Impact factor: 5.103

10.  Transforming growth factor-beta-stimulated endocardial cell transformation is dependent on Par6c regulation of RhoA.

Authors:  Todd A Townsend; Jeffrey L Wrana; George E Davis; Joey V Barnett
Journal:  J Biol Chem       Date:  2008-03-14       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.